15mg tirzepatide Mounjaro KwikPen (Tirzepatide Injection 2.4 ml) Tirzepatide – 60 mg Vial

Most studies report an increased sensitivity to experimental pain and, therefore, a decreased pain threshold in depressed compared to non-depressed subjects especially when emotional aspects of experimental pain are taken into account (Ushinsky et al., 2013)

In July, the European Medicines Agency announced it was looking into mental health side effects associated with Ozempic, including thoughts of self-harm and suicide

[1] Although the FDA primarily approved Mounjaro for managing type 2 diabetes and controlling blood sugar, it has also shown significant promise in supporting weight loss

We verified this calculation in two ways